Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:businessModel |
venture creation
|
| gptkbp:CEO |
gptkb:James_Peyer
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
aging-related diseases
longevity therapeutics |
| gptkbp:foundedYear |
2019
|
| gptkbp:founder |
gptkb:Aaron_Cravens
gptkb:James_Peyer |
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cambrian Biopharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Khosla_Ventures
gptkb:Lux_Capital gptkb:Future_Ventures |
| gptkbp:mission |
to develop medicines that target the causes of aging
|
| gptkbp:portfolioCompany |
gptkb:Sensei_Biotherapeutics
gptkb:Amplifier gptkb:Tally_Health |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.cambrianbio.com/
|
| gptkbp:bfsParent |
gptkb:Laura_Deming
|
| gptkbp:bfsLayer |
6
|